Digital health talks the talk, trips in walking the walk

With more than 165,000 healthcare apps available to consumers, the variety of mobile applications isn't in doubt. But the functionality is another issue. While healthcare providers are interested in using such apps to improve engagement and care delivery, adoption is limited due to barriers like a lack of scientific evidence, limited integration and confusion around regulatory and privacy issues.

 

Even with the number of mHealth apps increasing, as well as the number of providers interested in utilizing the technology, barriers can black true interoperability.

Read the full article by clicking below:

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.